Description
Sudokof Antitussive Syrup is a combination medication manufactured by Incepta Pharmaceuticals Ltd., formulated to provide symptomatic relief from upper respiratory tract disorders. Each 5 ml of the syrup contains Dextromethorphan HBr 20 mg, Phenylephrine HCl 10 mg, and Triprolidine HCl 2.5 mg. Dextromethorphan serves as a non-narcotic antitussive agent, suppressing the cough reflex in the brain's medulla, making it effective for dry, non-productive coughs. Phenylephrine acts as a decongestant by stimulating alpha-adrenergic receptors, leading to vasoconstriction in nasal passages and reducing swelling and congestion. Triprolidine is an antihistamine that blocks histamine receptors, alleviating symptoms like sneezing, runny nose, and itching. This combination addresses multiple symptoms associated with colds, hay fever, and other upper respiratory allergies. Sudokof Antitussive Syrup is available in a 100 ml bottle, with a retail price of approximately
.jpg)
.jpg)
.png)
.webp)
.jpg)
.jpg)
 100 IU 3 ML.webp)
.jpeg)
.jpg)
.jpeg)
.webp)
.webp)
.jpeg)
.jpeg)
.jpg)
 400MG.jpg)
.jpg)
.jpg)
Change Language